Post-transplantation cyclophosphamide is associated with increased bacterial infections

Incidence, etiology, risk factors, and outcomes of pre‐engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation

(2022) Mobil Akhmedov et al.   Transplant Infectious Disease

Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil As the New Standard for Graft-Versus-Host Disease (GVHD) Prophylaxis in Reduced Intensity Conditioning: Results from Phase III BMT CTN 1703

(2022) Shernan G Holtan et al.   BLOOD

Post-Transplant Cyclophosphamide (PTCy) is Associated with Increased Cytomegalovirus Infection: A CIBMTR Analysis

(2021) Scott R Goldsmith et al.   BLOOD

The impact of graft cell source on bloodstream infection in the first 100 days after allogeneic hematopoietic cell transplantation

(2021) Shinsuke Takagi et al.   BONE MARROW TRANSPLANTATION

Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

(2021) Arnon Nagler et al.   Journal of Hematology & Oncology

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

(2021) Albert Esquirol et al.   BONE MARROW TRANSPLANTATION

Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐ versus ‐host disease prophylaxis and haploidentical stem cell transplantation

(2021) Carolyn M. Mulroney et al.   BRITISH JOURNAL OF HAEMATOLOGY

Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching

(2020) Chiara Oltolini et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation Studies

(2020) Soyoung Kim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide

(2020) Jonathan A. Webster et al.   Blood Advances

Bloodstream infection (BSI) due to Vancomycin-Resistant Enterococcus (VRE) is associated with increased mortality after hematopoietic cell transplantation for acute leukemia and myelodysplastic syndrome: A multicenter, retrospective cohort study

(2019) Genovefa A Papanicolaou et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)

(2019) Amandine Fayard et al.   BONE MARROW TRANSPLANTATION

Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies

(2019) Sunita Nathan et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post‐transplantation cyclophosphamide

(2019) Dixie Huntley et al.   Transplant Infectious Disease

How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide

(2019) Shannon R. McCurdy et al.   Hematology-American Society of Hematology Education Program

Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor

(2018) Malgorzata Mikulska et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation

(2018) Celalettin Ustun et al.   BONE MARROW TRANSPLANTATION

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation

(2016) Karen Ballen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

(2016) M. Mielcarek et al.   BLOOD

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

(2016) Scott R. Goldsmith et al.   HAEMATOLOGICA

Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation

(2016) Michael Slade et al.   Transplant Infectious Disease

Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

(2016) Scott R. Goldsmith et al.   HAEMATOLOGICA

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections (MBI-LCBI): Descriptive Analysis of Data Reported to National Healthcare Safety Network (NHSN), 2013

(2015) Lauren Epstein et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis

(2015) R. Crocchiolo et al.   Transplant Infectious Disease

Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infection: Results from a Field Test of a New National Healthcare Safety Network Definition

(2013) Isaac See et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation

(2012) Stefan O. Ciurea et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Enterococcal Bacteremia Is Associated With Increased Risk of Mortality in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

(2012) J. Vydra et al.   CLINICAL INFECTIOUS DISEASES

Decreased Infections in Recipients of Unrelated Donor Hematopoietic Cell Transplantation from Donors with an Activating KIR Genotype

(2010) Marcie Tomblyn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION